The global market for Buclizine was estimated to be worth US$ 612 million in 2023 and is forecast to a readjusted size of US$ 820.1 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

Buclizine - Market

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Buclizine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Buclizine by region & country, by Type, and by Application.

The Buclizine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buclizine.

Market Segmentation

Scope of Buclizine - Market Report

Report Metric	Details
Report Name	Buclizine - Market
Forecasted market size in 2030	US$ 820.1 million
CAGR	4.3%
Forecasted years	2024 - 2030
Segment by Type:	Hospital Drug Store
Segment by Application	Antiallergic Agent Histamine H₁-Receptor Antagonist
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma, HUA Shin Chemical Pharmaceutical, Peili Pharmaceutical, Pfizer, Sinphar, Al Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Buclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Buclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Buclizine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Buclizine - Market size in 2030?

Ans: The Buclizine - Market size in 2030 will be US$ 820.1 million.

Who are the main players in the Buclizine - Market report?

Ans: The main players in the Buclizine - Market are Stuart Pharmaceuticals, Laboratorios Rocnarf, UCB, Mankind Pharma, Johnson and Johnson, Meider Pharma, Sanofi, MK Pharma, HUA Shin Chemical Pharmaceutical, Peili Pharmaceutical, Pfizer, Sinphar, Al Pharm

What are the Application segmentation covered in the Buclizine - Market report?

Ans: The Applications covered in the Buclizine - Market report are Antiallergic Agent, Histamine H₁-Receptor Antagonist

What are the Type segmentation covered in the Buclizine - Market report?

Ans: The Types covered in the Buclizine - Market report are Hospital, Drug Store

1 Market Overview

1.1 Buclizine Product Introduction

1.2 Global Buclizine Market Size Forecast

1.2.1 Global Buclizine Sales Value (2019-2030)

1.2.2 Global Buclizine Sales Volume (2019-2030)

1.2.3 Global Buclizine Sales Price (2019-2030)

1.3 Buclizine Market Trends & Drivers

1.3.1 Buclizine Industry Trends

1.3.2 Buclizine Market Drivers & Opportunity

1.3.3 Buclizine Market Challenges

1.3.4 Buclizine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Buclizine Players Revenue Ranking (2023)

2.2 Global Buclizine Revenue by Company (2019-2024)

2.3 Global Buclizine Players Sales Volume Ranking (2023)

2.4 Global Buclizine Sales Volume by Company Players (2019-2024)

2.5 Global Buclizine Average Price by Company (2019-2024)

2.6 Key Manufacturers Buclizine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Buclizine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Buclizine

2.9 Buclizine Market Competitive Analysis

2.9.1 Buclizine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Buclizine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buclizine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Hospital

3.1.2 Drug Store

3.2 Global Buclizine Sales Value by Type

3.2.1 Global Buclizine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Buclizine Sales Value, by Type (2019-2030)

3.2.3 Global Buclizine Sales Value, by Type (%) (2019-2030)

3.3 Global Buclizine Sales Volume by Type

3.3.1 Global Buclizine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Buclizine Sales Volume, by Type (2019-2030)

3.3.3 Global Buclizine Sales Volume, by Type (%) (2019-2030)

3.4 Global Buclizine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Antiallergic Agent

4.1.2 Histamine H₁-Receptor Antagonist

4.2 Global Buclizine Sales Value by Application

4.2.1 Global Buclizine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Buclizine Sales Value, by Application (2019-2030)

4.2.3 Global Buclizine Sales Value, by Application (%) (2019-2030)

4.3 Global Buclizine Sales Volume by Application

4.3.1 Global Buclizine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Buclizine Sales Volume, by Application (2019-2030)

4.3.3 Global Buclizine Sales Volume, by Application (%) (2019-2030)

4.4 Global Buclizine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Buclizine Sales Value by Region

5.1.1 Global Buclizine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Buclizine Sales Value by Region (2019-2024)

5.1.3 Global Buclizine Sales Value by Region (2025-2030)

5.1.4 Global Buclizine Sales Value by Region (%), (2019-2030)

5.2 Global Buclizine Sales Volume by Region

5.2.1 Global Buclizine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Buclizine Sales Volume by Region (2019-2024)

5.2.3 Global Buclizine Sales Volume by Region (2025-2030)

5.2.4 Global Buclizine Sales Volume by Region (%), (2019-2030)

5.3 Global Buclizine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Buclizine Sales Value, 2019-2030

5.4.2 North America Buclizine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Buclizine Sales Value, 2019-2030

5.5.2 Europe Buclizine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Buclizine Sales Value, 2019-2030

5.6.2 Asia Pacific Buclizine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Buclizine Sales Value, 2019-2030

5.7.2 South America Buclizine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Buclizine Sales Value, 2019-2030

5.8.2 Middle East & Africa Buclizine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Buclizine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Buclizine Sales Value

6.2.1 Key Countries/Regions Buclizine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Buclizine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Buclizine Sales Value, 2019-2030

6.3.2 United States Buclizine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Buclizine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Buclizine Sales Value, 2019-2030

6.4.2 Europe Buclizine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Buclizine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Buclizine Sales Value, 2019-2030

6.5.2 China Buclizine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Buclizine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Buclizine Sales Value, 2019-2030

6.6.2 Japan Buclizine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Buclizine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Buclizine Sales Value, 2019-2030

6.7.2 South Korea Buclizine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Buclizine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Buclizine Sales Value, 2019-2030

6.8.2 Southeast Asia Buclizine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Buclizine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Buclizine Sales Value, 2019-2030

6.9.2 India Buclizine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Buclizine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Stuart Pharmaceuticals

7.1.1 Stuart Pharmaceuticals Company Information

7.1.2 Stuart Pharmaceuticals Introduction and Business Overview

7.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Stuart Pharmaceuticals Buclizine Product Offerings

7.1.5 Stuart Pharmaceuticals Recent Development

7.2 Laboratorios Rocnarf

7.2.1 Laboratorios Rocnarf Company Information

7.2.2 Laboratorios Rocnarf Introduction and Business Overview

7.2.3 Laboratorios Rocnarf Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Laboratorios Rocnarf Buclizine Product Offerings

7.2.5 Laboratorios Rocnarf Recent Development

7.3 UCB

7.3.1 UCB Company Information

7.3.2 UCB Introduction and Business Overview

7.3.3 UCB Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 UCB Buclizine Product Offerings

7.3.5 UCB Recent Development

7.4 Mankind Pharma

7.4.1 Mankind Pharma Company Information

7.4.2 Mankind Pharma Introduction and Business Overview

7.4.3 Mankind Pharma Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mankind Pharma Buclizine Product Offerings

7.4.5 Mankind Pharma Recent Development

7.5 Johnson and Johnson

7.5.1 Johnson and Johnson Company Information

7.5.2 Johnson and Johnson Introduction and Business Overview

7.5.3 Johnson and Johnson Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Johnson and Johnson Buclizine Product Offerings

7.5.5 Johnson and Johnson Recent Development

7.6 Meider Pharma

7.6.1 Meider Pharma Company Information

7.6.2 Meider Pharma Introduction and Business Overview

7.6.3 Meider Pharma Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Meider Pharma Buclizine Product Offerings

7.6.5 Meider Pharma Recent Development

7.7 Sanofi

7.7.1 Sanofi Company Information

7.7.2 Sanofi Introduction and Business Overview

7.7.3 Sanofi Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Sanofi Buclizine Product Offerings

7.7.5 Sanofi Recent Development

7.8 MK Pharma

7.8.1 MK Pharma Company Information

7.8.2 MK Pharma Introduction and Business Overview

7.8.3 MK Pharma Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 MK Pharma Buclizine Product Offerings

7.8.5 MK Pharma Recent Development

7.9 HUA Shin Chemical Pharmaceutical

7.9.1 HUA Shin Chemical Pharmaceutical Company Information

7.9.2 HUA Shin Chemical Pharmaceutical Introduction and Business Overview

7.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 HUA Shin Chemical Pharmaceutical Buclizine Product Offerings

7.9.5 HUA Shin Chemical Pharmaceutical Recent Development

7.10 Peili Pharmaceutical

7.10.1 Peili Pharmaceutical Company Information

7.10.2 Peili Pharmaceutical Introduction and Business Overview

7.10.3 Peili Pharmaceutical Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Peili Pharmaceutical Buclizine Product Offerings

7.10.5 Peili Pharmaceutical Recent Development

7.11 Pfizer

7.11.1 Pfizer Company Information

7.11.2 Pfizer Introduction and Business Overview

7.11.3 Pfizer Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Pfizer Buclizine Product Offerings

7.11.5 Pfizer Recent Development

7.12 Sinphar

7.12.1 Sinphar Company Information

7.12.2 Sinphar Introduction and Business Overview

7.12.3 Sinphar Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Sinphar Buclizine Product Offerings

7.12.5 Sinphar Recent Development

7.13 Al Pharm

7.13.1 Al Pharm Company Information

7.13.2 Al Pharm Introduction and Business Overview

7.13.3 Al Pharm Buclizine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Al Pharm Buclizine Product Offerings

7.13.5 Al Pharm Recent Development

8 Industry Chain Analysis

8.1 Buclizine Industrial Chain

8.2 Buclizine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Buclizine Sales Model

8.5.2 Sales Channel

8.5.3 Buclizine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Stuart Pharmaceuticals

HUA Shin Chemical Pharmaceutical

List of Tables

Table 1. Buclizine Market Trends

Table 2. Buclizine Market Drivers & Opportunity

Table 3. Buclizine Market Challenges

Table 4. Buclizine Market Restraints

Table 5. Global Buclizine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Buclizine Revenue Market Share by Company (2019-2024)

Table 7. Global Buclizine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Buclizine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Buclizine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Buclizine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Buclizine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Buclizine

Table 13. Global Buclizine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buclizine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Buclizine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Buclizine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Buclizine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Buclizine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Buclizine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Buclizine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Buclizine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Buclizine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Buclizine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Buclizine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Buclizine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Buclizine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Buclizine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Buclizine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Buclizine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Buclizine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Buclizine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Buclizine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Buclizine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Buclizine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Buclizine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Buclizine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Buclizine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Buclizine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Buclizine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Buclizine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Buclizine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Buclizine Sales Value by Region (2019-2024) & (%)

Table 44. Global Buclizine Sales Value by Region (2025-2030) & (%)

Table 45. Global Buclizine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Buclizine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Buclizine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Buclizine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Buclizine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Buclizine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Buclizine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Buclizine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Buclizine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Buclizine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Buclizine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Buclizine Sales Volume, (2025-2030) & (K Units)

Table 57. Stuart Pharmaceuticals Company Information

Table 58. Stuart Pharmaceuticals Introduction and Business Overview

Table 59. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Stuart Pharmaceuticals Buclizine Product Offerings

Table 61. Stuart Pharmaceuticals Recent Development

Table 62. Laboratorios Rocnarf Company Information

Table 63. Laboratorios Rocnarf Introduction and Business Overview

Table 64. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Laboratorios Rocnarf Buclizine Product Offerings

Table 66. Laboratorios Rocnarf Recent Development

Table 67. UCB Company Information

Table 68. UCB Introduction and Business Overview

Table 69. UCB Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. UCB Buclizine Product Offerings

Table 71. UCB Recent Development

Table 72. Mankind Pharma Company Information

Table 73. Mankind Pharma Introduction and Business Overview

Table 74. Mankind Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Mankind Pharma Buclizine Product Offerings

Table 76. Mankind Pharma Recent Development

Table 77. Johnson and Johnson Company Information

Table 78. Johnson and Johnson Introduction and Business Overview

Table 79. Johnson and Johnson Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Johnson and Johnson Buclizine Product Offerings

Table 81. Johnson and Johnson Recent Development

Table 82. Meider Pharma Company Information

Table 83. Meider Pharma Introduction and Business Overview

Table 84. Meider Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Meider Pharma Buclizine Product Offerings

Table 86. Meider Pharma Recent Development

Table 87. Sanofi Company Information

Table 88. Sanofi Introduction and Business Overview

Table 89. Sanofi Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Sanofi Buclizine Product Offerings

Table 91. Sanofi Recent Development

Table 92. MK Pharma Company Information

Table 93. MK Pharma Introduction and Business Overview

Table 94. MK Pharma Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. MK Pharma Buclizine Product Offerings

Table 96. MK Pharma Recent Development

Table 97. HUA Shin Chemical Pharmaceutical Company Information

Table 98. HUA Shin Chemical Pharmaceutical Introduction and Business Overview

Table 99. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. HUA Shin Chemical Pharmaceutical Buclizine Product Offerings

Table 101. HUA Shin Chemical Pharmaceutical Recent Development

Table 102. Peili Pharmaceutical Company Information

Table 103. Peili Pharmaceutical Introduction and Business Overview

Table 104. Peili Pharmaceutical Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Peili Pharmaceutical Buclizine Product Offerings

Table 106. Peili Pharmaceutical Recent Development

Table 107. Pfizer Company Information

Table 108. Pfizer Introduction and Business Overview

Table 109. Pfizer Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Pfizer Buclizine Product Offerings

Table 111. Pfizer Recent Development

Table 112. Sinphar Company Information

Table 113. Sinphar Introduction and Business Overview

Table 114. Sinphar Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Sinphar Buclizine Product Offerings

Table 116. Sinphar Recent Development

Table 117. Al Pharm Company Information

Table 118. Al Pharm Introduction and Business Overview

Table 119. Al Pharm Buclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Al Pharm Buclizine Product Offerings

Table 121. Al Pharm Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Buclizine Downstream Customers

Table 125. Buclizine Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Buclizine Product Picture

Figure 2. Global Buclizine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Buclizine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Buclizine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Buclizine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Buclizine Report Years Considered

Figure 7. Global Buclizine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Buclizine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Buclizine Revenue in 2023

Figure 10. Buclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Hospital Picture

Figure 12. Drug Store Picture

Figure 13. Global Buclizine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Buclizine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Buclizine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Buclizine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Buclizine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Antiallergic Agent

Figure 19. Product Picture of Histamine H₁-Receptor Antagonist

Figure 20. Global Buclizine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Buclizine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Buclizine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Buclizine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Buclizine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Buclizine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Buclizine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Buclizine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Buclizine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Buclizine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Buclizine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Buclizine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Buclizine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Buclizine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Buclizine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Buclizine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Buclizine Sales Volume (%), (2019-2030)

Figure 37. United States Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Buclizine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Buclizine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Buclizine Sales Value by Application (%), 2023 VS 2030

Figure 58. Buclizine Industrial Chain

Figure 59. Buclizine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions